54 research outputs found
Kapsula
Selections from the 2015 Conference of the Contemporary Art, Design and New Media Art Histories Masters Progra
Kapsula
Selections from the 2015 Conference of the Contemporary Art, Design and New Media Art Histories Masters Progra
Personalized Nutrition as a Key Contributor to Improving Radiation Response in Breast Cancer
Understanding metabolic and immune regulation inherent to patient populations is key to improving the radiation response for our patients. To date, radiation therapy regimens are prescribed based on tumor type and stage. Patient populations who are noted to have a poor response to radiation such as those of African American descent, those who have obesity or metabolic syndrome, or senior adult oncology patients, should be considered for concurrent therapies with radiation that will improve response. Here, we explore these populations of breast cancer patients, who frequently display radiation resistance and increased mortality rates, and identify the molecular underpinnings that are, in part, responsible for the radiation response and that result in an immune-suppressive tumor microenvironment. The resulting immune phenotype is discussed to understand how antitumor immunity could be improved. Correcting nutrient deficiencies observed in these populations should be considered as a means to improve the therapeutic index of radiation therapy
The Lantern Vol. 74, No. 1, Fall 2006
âą Seven Haikus About Insomnia âą Lunch Hour âą Divorced Parents and Flower Guts âą 24 âą Lily âą Growth âą Narcissistically Admiring You âą Mysterious Avocado âą Aloha Roast âą Summer âą Lines âą Internalizing âą San Francisco âą Numb Candle âą Moments No. 1 âą Tanka âą Euphemism âą We be Malllllll âą Dragon Magic âą Time for the Magic Show âą Green âą Job âą The Shire âą Venom âą The Seasons of Love âą The Position âą Fragments of an Artist âą Peace âą Vagabond Nights âą Rerum Concordia Discorshttps://digitalcommons.ursinus.edu/lantern/1169/thumbnail.jp
Impact of Optimized Breastfeeding on the Costs of Necrotizing Enterocolitis in Extremely Low Birthweight Infants
To estimate risk of NEC for ELBW infants as a function of preterm formula and maternal milk (MM) intake and calculate the impact of suboptimal feeding on NEC incidence and costs
Effect of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker initiation on organ support-free days in patients hospitalized with COVID-19
IMPORTANCE Overactivation of the renin-angiotensin system (RAS) may contribute to poor clinical outcomes in patients with COVID-19.
Objective To determine whether angiotensin-converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB) initiation improves outcomes in patients hospitalized for COVID-19.
DESIGN, SETTING, AND PARTICIPANTS In an ongoing, adaptive platform randomized clinical trial, 721 critically ill and 58 nonâcritically ill hospitalized adults were randomized to receive an RAS inhibitor or control between March 16, 2021, and February 25, 2022, at 69 sites in 7 countries (final follow-up on June 1, 2022).
INTERVENTIONS Patients were randomized to receive open-label initiation of an ACE inhibitor (nâ=â257), ARB (nâ=â248), ARB in combination with DMX-200 (a chemokine receptor-2 inhibitor; nâ=â10), or no RAS inhibitor (control; nâ=â264) for up to 10 days.
MAIN OUTCOMES AND MEASURES The primary outcome was organ supportâfree days, a composite of hospital survival and days alive without cardiovascular or respiratory organ support through 21 days. The primary analysis was a bayesian cumulative logistic model. Odds ratios (ORs) greater than 1 represent improved outcomes.
RESULTS On February 25, 2022, enrollment was discontinued due to safety concerns. Among 679 critically ill patients with available primary outcome data, the median age was 56 years and 239 participants (35.2%) were women. Median (IQR) organ supportâfree days among critically ill patients was 10 (â1 to 16) in the ACE inhibitor group (nâ=â231), 8 (â1 to 17) in the ARB group (nâ=â217), and 12 (0 to 17) in the control group (nâ=â231) (median adjusted odds ratios of 0.77 [95% bayesian credible interval, 0.58-1.06] for improvement for ACE inhibitor and 0.76 [95% credible interval, 0.56-1.05] for ARB compared with control). The posterior probabilities that ACE inhibitors and ARBs worsened organ supportâfree days compared with control were 94.9% and 95.4%, respectively. Hospital survival occurred in 166 of 231 critically ill participants (71.9%) in the ACE inhibitor group, 152 of 217 (70.0%) in the ARB group, and 182 of 231 (78.8%) in the control group (posterior probabilities that ACE inhibitor and ARB worsened hospital survival compared with control were 95.3% and 98.1%, respectively).
CONCLUSIONS AND RELEVANCE In this trial, among critically ill adults with COVID-19, initiation of an ACE inhibitor or ARB did not improve, and likely worsened, clinical outcomes.
TRIAL REGISTRATION ClinicalTrials.gov Identifier: NCT0273570
A Citation Based View of the Ontology Community in Philosophy
While many bibliometric techniques have been employed to represent the structure of academic research communities over the years, much of this work has been conducted on scientific fields as opposed to those in the humanities. Here we use graphing techniques to present two networks that allow us to explore the structure of a subset of the philosophy community by mapping the citations between philosophical texts on the topic of ontology (the study of what exists). We find a citation gap between philosophers studying material and abstract objects, and between analytic and continental ontologists, but other predictions were not confirmed by this method. We conclude by considering several additional methods for further exploring both the structure of philosophy and other disciplines in the humanities
Characterization of Hydrodynamic Properties from Free Vibration Tests of a Large-Scale Bridge Model
To accurately predict the dynamic response of a structure subjected to fluid induced loading, a thorough understanding of the dynamic properties (mass, stiffness, and damping) and associated interactions is required. Limited data are available to characterize dynamic fluidâstructure interactions. Data are particularly limited for large-scale and flexible structural models. This article reports the results of the first free vibration tests of a dynamic large-scale laboratory highway bridge superstructure model. The dynamic response characteristics of the model were extracted and analyzed from free vibration tests under varying levels of water submersion and for different horizontal substructure flexibilities. The nature of the damping response was identified based on the empirically measured logarithmic decrements of the modelâs free vibration displacement amplitudes, and a suitable equation of motion (EOM) was subsequently developed. Using the classical fourth-order RungeâKutta method, the EOM was solved for the different test trials and the dynamic properties of the model were obtained through an optimization approach. The concept of added mass was introduced to explain the observed decrease in natural frequency with increasing levels of water submersion. Finally, added mass factor was computed for the case where the water level was even with the top of the bridge superstructure model. This study provides a suitable EOM needed for numerical simulations of this and similar models that study fluidâstructure interaction and also provides a methodology for establishing the structural dynamic properties of generalized hydrodynamic analytical models
entropy input file
Input file for entropy including 1286 individuals and 12666 loci. Data are in genotype likelihood form - this file was made by simplifying a VCF using the script vcf2mpgl.p
Predictor variables for model averaging
Environmental and historical data associated with locations where hybrid individuals were sampled. Input for model_averaging_trout_MuMIn.
- âŠ